Anavex Life Sciences
$2.817
USD
Last updated on --.
24h volume163.99K
24h highest2.8150 USD
24h lowest2.6600 USD
24h Price movement+6.50%
AVXL recent prices
24 Hours
+6.50%+$0.172
30 days
-21.43%-$0.72
60 days
-10.81%-$0.32
90 days
-43.23%-$2.010
Key data
Previous close2.6450 USD
Market cap280.80M USD
Volume163.99K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.43000 USD
Net income (FY)-39.95M USD
Revenue (FY)--
Last report dateFeb 9, 2026
About Anavex Life Sciences
HeadquartersNEW YORK
Employees (FY)34.00
Net income per employee (FY)-1.17M USD
Listed onNasdaq
AVXL conversion tables
 |  |
|---|---|
| 0.5 AVXL | 1.408 USD |
| 1 AVXL | 2.817 USD |
| 5 AVXL | 14.08 USD |
| 10 AVXL | 28.17 USD |
| |
|---|---|
| 0.5 USD | 0.17749 AVXL |
| 1 USD | 0.35499 AVXL |
| 5 USD | 1.774 AVXL |
| 10 USD | 3.549 AVXL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AVXL is trading at $2.817, +6.50% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AVXL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AVXL is currently trading at $2.817, +6.50% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AVXL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AVXL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AVXL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AVXL's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Anavex Life Sciences's market cap is currently 280.80M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume163.99K
24h highest2.8150 USD
24h lowest2.6600 USD
24h Price movement+6.50%
Start trade with AVXL Perpetual
Sign up to trade